FY17
Assets13.74
Net Worth3.64
Total Debt7.50
RevenueAnnualised basis[●] [●]
EBITDAAnnualised basis[●] [●]
PATAnnualised basis[●] [●]
EBITDA Margin (%)[●]
At a glance
Updated 2026-09-06Vanta Bioscience is an IPO with an issue size of ₹7.56 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹7.56 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets13.74₹ Cr
Net Worth3.64₹ Cr
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Vanta Bioscience IPO | — | - | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Vanta Bioscience without missing an update
Register for subscription, GMP, allotment and listing notifications.